Genpact Limited
G · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $7 | $8 | $9 | $8 |
| - Cash | $1 | $1 | $1 | $1 |
| + Debt | $1 | $2 | $1 | $1 |
| Enterprise Value | $8 | $9 | $10 | $8 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 2.9% | 3.3% | -2.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 36.4% | 35.9% | 35.3% | 35.7% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 17.8% | 17.2% | 17.6% | 18.2% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 11.3% | 10.6% | 10.8% | 11.4% |
| EPS Diluted | 0.83 | 0.75 | 0.73 | 0.79 |
| % Growth | 10.7% | 2.7% | -7.6% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |